Product Code: PM3047
The global glycomics/glycobiology market size is expected to reach USD 5.24 billion by 2032, according to a new study by Polaris Market Research. The report "Glycomics/Glycobiology Market Share, Size, Trends, Industry Analysis Report, By Product (Enzymes, Kits, Reagents, and Instruments); By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Rising investments and implementation on glycomics research by both government and private organizations, high development of many novel drugs & therapeutics, and progress in proteomics are key factors boosting global market growth.
In the last decades, glycomics has gained high popularity as an emerging field of research and has a wide range of applications in oncology, diagnostics, drug discovery, and immunology and is also being used in determining cancer cells and regulating cell regulation. Thus, the market is expected to grow significantly and have huge opportunities shortly. For instance, in April 2022, Bruker announced the availability of its new novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF flex combined with unbiased lipidomics, metabolomics, and glycomics tissue imaging.
The growing prevalence of cancer and other related diseases among people worldwide has led to the rising use of glycobiology in research activities for cancer treatment, because of the relevance of surface glycan in both neoplastic and metastatic characteristics of tumor cells present in human body. Lung cancer amounted to a leading number of cancer deaths, with a total estimated 1.8 million deaths followed by colorectal with about 1 million deaths.
Furthermore, precision medicine has rapidly grown in recent years and many large pharma and biotech companies are investing larger funds to develop various targeted drugs, which can be effectively used for a specific patient group. In addition, a researcher has also shown that the mutation in glycosyltransferases or other related enzymes alters the glycome and also causes over 100 types of human congenital disorders.
Glycomics/Glycobiology Market Report Highlights:
Instruments segment accounted for largest market share in 2022 on account of increasing adoption of innovative instruments across various applications including diagnostics
Drug discovery & development segment held the largest market revenue share in 2022, owing to the increase in prevalence of personalized medicine to address chronic diseases
Pharmaceutical & biotechnology companies are likely to be the largest end-use segment over the forecast period due to the increased investment and efforts by the companies on technology development and product enhancement.
North America dominated the global market in 2022, which is highly attributed to the growing proliferation of precision medicine and increasing healthcare spending in countries like the US and Canada.
The global key market players include Thermo Fisher Scientific, Agilent Technology, New England Biolabs, Sumitomo Bakelite, and Danaher Corporation
Polaris Market Research has segmented the glycomics/glycobiology market report based on product, application, end-use, and region:
Glycomics/Glycobiology, Product Outlook (Revenue - USD Billion, 2019 - 2032)
Enzymes
Kits
Reagents
Instruments
Glycomics/Glycobiology, Application Outlook (Revenue - USD Billion, 2019 - 2032)
Drug Discovery & Development
Diagnostics
Others
Glycomics/Glycobiology, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)
Academic & Research Institute
Pharmaceutical & Biotechnology Companies
CROs
Glycomics/Glycobiology, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
3. Research Methodology
- 3.1. Overview
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Glycomics/Glycobiology Market Insights
- 4.1. Glycomics/Glycobiology Market - End Use Snapshot
- 4.2. Glycomics/Glycobiology Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Technological advancements
- 4.2.1.2. Rising investments in R&D of pharmaceutical and biotechnology companies
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost of tools
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Glycomics/Glycobiology Market End Use Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Glycomics/Glycobiology Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 5.3. Enzymes
- 5.3.1. Global Glycomics/Glycobiology Market, by Enzymes, by Region, 2019-2032 (USD Billion)
- 5.4. Kits
- 5.4.1. Global Glycomics/Glycobiology Market, by Kits, by Region, 2019-2032 (USD Billion)
- 5.5. Reagents
- 5.5.1. Global Glycomics/Glycobiology Market, Reagents, by Region, 2019-2032 (USD Billion)
- 5.6. Instruments
- 5.6.1. Global Glycomics/Glycobiology Market, Instruments, by Region, 2019-2032 (USD Billion)
6. Global Glycomics/Glycobiology Market, by Application
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 6.3. Drug Discovery & Development
- 6.3.1. Global Glycomics/Glycobiology Market, by Drug Discovery & Development, by Region, 2019-2032 (USD Billion)
- 6.4. Diagnostics
- 6.4.1. Global Glycomics/Glycobiology Market, by Diagnostics, by Region, 2019-2032 (USD Billion)
- 6.5. Others
- 6.5.1. Global Glycomics/Glycobiology Market, by Others, by Region, 2019-2032 (USD Billion)
7. Global Glycomics/Glycobiology Market, by End Use
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 7.3. Academic & Research Institute
- 7.3.1. Global Glycomics/Glycobiology Market, by Academic & Research Institute, By Region, 2019-2032 (USD Billion)
- 7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Global Glycomics/Glycobiology Market, by Pharmaceutical & Biotechnology Companies, By Region, 2019-2032 (USD Billion)
- 7.5. CROS
- 7.5.1. Global Glycomics/Glycobiology Market, by CROS, By Region, 2019-2032 (USD Billion)
8. Global Glycomics/Glycobiology Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Glycomics/Glycobiology Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Glycomics/Glycobiology Market - North America
- 8.3.1. North America: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.3.2. North America: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.3.3. North America: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.3.4. Glycomics/Glycobiology Market - U.S.
- 8.3.4.1. U.S.: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.3.5. Glycomics/Glycobiology Market - Canada
- 8.3.5.1. Canada: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.4. Glycomics/Glycobiology Market - Europe
- 8.4.1. Europe: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.4.3. Europe: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.4.4. Glycomics/Glycobiology Market - UK
- 8.4.4.1. UK: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.4.5. Glycomics/Glycobiology Market - France
- 8.4.5.1. France: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.4.5.3. France: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.4.6. Glycomics/Glycobiology Market - Germany
- 8.4.6.1. Germany: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.4.7. Glycomics/Glycobiology Market - Italy
- 8.4.7.1. Italy: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.4.8. Glycomics/Glycobiology Market - Spain
- 8.4.8.1. Spain: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.4.9. Glycomics/Glycobiology Market - Netherlands
- 8.4.9.1. Netherlands: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.4.10. Glycomics/Glycobiology Market - Russia
- 8.4.10.1. Russia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.5. Glycomics/Glycobiology Market - Asia Pacific
- 8.5.1. Asia Pacific: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.5.4. Glycomics/Glycobiology Market - China
- 8.5.4.1. China: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.5.4.3. China: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.5.5. Glycomics/Glycobiology Market - India
- 8.5.5.1. India: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.5.5.3. India: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.5.6. Glycomics/Glycobiology Market - Malaysia
- 8.5.6.1. Malaysia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.5.7. Glycomics/Glycobiology Market - Japan
- 8.5.7.1. Japan: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.5.8. Glycomics/Glycobiology Market - Indonesia
- 8.5.8.1. Indonesia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.5.9. Glycomics/Glycobiology Market - South Korea
- 8.5.9.1. South Korea: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.6. Glycomics/Glycobiology Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.6.4. Glycomics/Glycobiology Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.6.5. Glycomics/Glycobiology Market - UAE
- 8.6.5.1. UAE: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.6.6. Glycomics/Glycobiology Market - Israel
- 8.6.6.1. Israel: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.6.7. Glycomics/Glycobiology Market - South Africa
- 8.6.7.1. South Africa: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.7. Glycomics/Glycobiology Market - Latin America
- 8.7.1. Latin America: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.7.4. Glycomics/Glycobiology Market - Mexico
- 8.7.4.1. Mexico: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.7.5. Glycomics/Glycobiology Market - Brazil
- 8.7.5.1. Brazil: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
- 8.7.6. Glycomics/Glycobiology Market - Argentina
- 8.7.6.1. Argentina: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Thermo Fisher Scientific
- 10.1.1. Company Overview
- 10.1.2. Financial PerApplicationance
- 10.1.3. Application Benchmarking
- 10.1.4. Recent Development
- 10.2. Merck
- 10.2.1. Company Overview
- 10.2.2. Financial PerApplicationance
- 10.2.3. Application Benchmarking
- 10.2.4. Recent Development
- 10.3. Agilent Technology
- 10.3.1. Company Overview
- 10.3.2. Financial PerApplicationance
- 10.3.3. Application Benchmarking
- 10.3.4. Recent Development
- 10.4. New England Biolabs
- 10.4.1. Company Overview
- 10.4.2. Financial PerApplicationance
- 10.4.3. Application Benchmarking
- 10.4.4. Recent Development
- 10.5. Danaher Corporation
- 10.5.1. Company Overview
- 10.5.2. Financial PerApplicationance
- 10.5.3. Application Benchmarking
- 10.5.4. Recent Development
- 10.6. Shimadzu Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial PerApplicationance
- 10.6.3. Application Benchmarking
- 10.6.4. Recent Development
- 10.7. Takara Bio
- 10.7.1. Company Overview
- 10.7.2. Financial PerApplicationance
- 10.7.3. Application Benchmarking
- 10.7.4. Recent Development
- 10.8. Waters Corporation
- 10.8.1. Company Overview
- 10.8.2. Financial PerApplicationance
- 10.8.3. Application Benchmarking
- 10.8.4. Recent Development
- 10.9. Sumitomo Bakelite
- 10.9.1. Company Overview
- 10.9.2. Financial PerApplicationance
- 10.9.3. Application Benchmarking
- 10.9.4. Recent Development
- 10.10. AMS Bio
- 10.10.1. Company Overview
- 10.10.2. Financial PerApplicationance
- 10.10.3. Application Benchmarking
- 10.10.4. Recent Development
- 10.11. Kode Biotech
- 10.11.1. Company Overview
- 10.11.2. Financial PerApplicationance
- 10.11.3. Application Benchmarking
- 10.11.4. Recent Development
- 10.12. Ray Biotech Life
- 10.12.1. Company Overview
- 10.12.2. Financial PerApplicationance
- 10.12.3. Application Benchmarking
- 10.12.4. Recent Development
- 10.13. Lectenz Bio
- 10.13.1. Company Overview
- 10.13.2. Financial PerApplicationance
- 10.13.3. Application Benchmarking
- 10.13.4. Recent Development
- 10.14. Glycomix
- 10.14.1. Company Overview
- 10.14.2. Financial PerApplicationance
- 10.14.3. Application Benchmarking
- 10.14.4. Recent Development
- 10.15. Ludger
- 10.15.1. Company Overview
- 10.15.2. Financial PerApplicationance
- 10.15.3. Application Benchmarking
- 10.15.4. Recent Development
- 10.16. Glyxera
- 10.16.1. Company Overview
- 10.16.2. Financial PerApplicationance
- 10.16.3. Application Benchmarking
- 10.16.4. Recent Development
- 10.17. IEC Group
- 10.17.1. Company Overview
- 10.17.2. Financial PerApplicationance
- 10.17.3. Application Benchmarking
- 10.17.4. Recent Development